Bowel Disease Suppliers Serving Libya
13 companies found
based inNess Ziona, ISRAEL
BiomX is developing both natural and engineered phage cocktails designed to target and destroy bacteria that affect the appearance of skin, as well as harmful bacteria in chronic diseases, such as cystic fibrosis, inflammatory bowel disease, atopic ...
based inCambridge, MASSACHUSETTS (USA)
Iterative Health is pioneering the use of artificial intelligence-based precision medicine in gastroenterology (GI), with the aim of helping to optimize clinical trials investigating treatment of inflammatory bowel disease (IBD) and improving the ...
based inCambridge, UNITED KINGDOM
DiagNodus Ltd is a medical diagnostics company which is pioneering the development of novel non-invasive methods of biological material collection and testing for colorectal disease detection. Producing patient-friendly highly sensitive diagnostic ...
DiagNodus has designed and patented methods for non-invasive collection and analysis of samples indicative of the state of the human bowel. The technology is based upon disease biomarker detection. The approach addresses a range of diagnostic, ...
based inDijon, FRANCE
At Exeliom Biosciences, we develop novel therapeutic approaches to unleash the therapeutic potential of key players in the Microbiome - Host interactions to fight immune-mediated diseases, starting with inflammatory bowel diseases. There is a time ...
Our research has led us to discover that patients suffering from inflammatory bowel diseases lack a crucial bacterium and, therefore, do not have a fair chance to fight their conditions. We have developed a single bacterial strain drug candidate to ...
based inTrieste, ITALY
Today Eurospital manufactures and commercializes pharmaceutical products, medical-surgical and diagnostic devices and a completely new line of gluten-free products. Throughout the years it extended its range of action by implementing strategic ...
based inPlano, TEXAS (USA)
Headquartered in Plano, Texas, AnX Robotica brings versatility in the development and integration of technologies including precise magnetic control, in house ASIC design, artificial intelligence, micro-optical imaging, image processing, and ...
based inSomerville, MASSACHUSETTS (USA)
Finch Therapeutics is a clinical-stage microbiome therapeutics company leveraging its Human-First Discovery platform to develop a novel class of orally administered biological drugs. With the capabilities to develop both complete and targeted ...
In collaboration with Takeda Pharmaceuticals, we are developing FIN-524 and FIN-525, orally administered, Targeted Consortia product candidates designed for the treatment of ulcerative colitis (UC) and Crohn’s disease (CD), respectively. UC ...
based inBuk-gu, SOUTH KOREA
JD Bioscience (JDB) is a group of experts in small molecule-based novel drug development. JD Bioscience was established by a team of highly experienced medicinal chemists, biologists, and clinicians in the field of endocrine and metabolic diseases. ...
IBD, including ulcerative colitis (UC) and crohn’s disease (CD) can be caused by genetic and environmental factors and can induces uncontrolled activation of intestinal immune cells. Pro-inflammatory cytokines, such as IL-6 and TNF, produced ...
based inOttawa, ONTARIO (CANADA)
MedBiome Inc. was launched in 2018 as the result of technologies developed at the University of Ottawa. MedBiome focuses on the development of Precision Microbiome Therapeutics and Precision Microbiome Nutrition that target the production of ...
based inParis, FRANCE
Enterome is pioneering the discovery and development of novel pharmaceuticals based on its unrivalled understanding of the interaction between the gut microbiome and the immune system – the Microbiome-Immunoinflammation Axis. Enterome is using this ...
EB1010 is an orally administered, GI-selective next generation IL-10 inducer designed to induce high local secretion of IL-10 for the treatment of Inflammatory Bowel Disease (IBD) and food allergy. EB1010 is a peptide that modulates the immune ...
based inBoston, MASSACHUSETTS (USA)
Accelerating Discovery in CNS, Cardiometabolic and Inflammatory Disease. We support our clients to achieve more in their target & biomarker programs. Our expertise, curated & disease enriched clinco-omic cohorts, tools and applications for insight ...
based inSeattle, WASHINGTON (USA)
Lumen Bioscience discovers, develops, and manufactures biologic drug candidates for highly prevalent diseases-many of which currently lack effective treatments. The company’s unique drug development and manufacturing platform offers the potential to ...
Inflammatory bowel disease (IBD) is a systemic autoimmune disease, but it has an obvious nexus with the gastrointestinal tract. The two main sub-varieties—Crohn’s disease and ulcerative colitis—have many available treatments on the ...
based inHuangpu District, CHINA
Moon (Guangzhou) Biotech Co., Ltd., with the title of National High-tech Enterprise, is an innovative biotechnology company focusing on the development and commercialization of microbial products and solutions. With a dedication to discover, ...